Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease

NCT00350974 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT00350974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00350974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
March 8, 2007
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hypertension